Resultados de la búsqueda
Escobar-Lopez L, Ochoa JP, Mirelis JG, Espinosa M, Navarro M, Gallego-Delgado M, Barriales-Villa R, Robles-Mezcua A, Basurte-Elorz MT, Gutiérrez García-Moreno L, Climent V, Jiménez-Jaimez J, Mogollón-Jiménez MV, Lopez J, Peña-Peña ML, García-Álvarez A, Brion M, Ripoll-Vera T, Palomino-Doza J, Tirón C, Idiazabal U, Brögger MN, García-Hernández S, Restrepo-Córdoba MA, Gonzalez-Lopez E, Méndez I, Sabater M, Villacorta E, Larrañaga-Moreira JM, Abecia A, Fernández AI, García-Pinilla JM, Rodríguez-Palomares JF, Gimeno-Blanes JR, Bayes-Genis A, Lara-Pezzi E, Domínguez F, Garcia-Pavia P Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy J Am Coll Cardiol (2021) 78:1682-1699
Pascual-Figal DA Biochemical or clinical heart failure, not so simple Eur J Heart Fail (2021) 23:465-67
Lecce L, Xu Y, V'Gangula B, Chandel N, Pothula V, Caudrillier A, Santini MP, d'Escamard V, Ceholski DK, Gorski PA, Ma L, Koplev S, Bjørklund MM, Björkegren JL, Boehm M, Bentzon JF, Fuster V, Kim HW, Weintraub NL, Baker AH, Bernstein E, Kovacic JC Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotype J Clin Invest (2021) 131:e131178
Guzik TJ, Fuster V Dynamic sustainability, a look at the philosophy behind one of Spain's flagship cardiovascular institutes, the CNIC Cardiovasc Res (2021) 117:e151-e155
Díaz-Munoz R, Valle-Caballero MJ, Sanchez-Gonzalez J, Pizarro G, García-Rubira JC, Escalera N, Fuster V, Fernández-Jiménez R, Ibanez B Intravenous metoprolol during ongoing STEMI ameliorates markers of ischemic injury: a METOCARD-CNIC trial electrocardiographic study Basic Res Cardiol (2021) 116:45
Link to the full text in Repisalud
Link to the full text in Repisalud
Rangel-Zuniga OA, Vals-Delgado C, Alcala-Diaz JF, Quintana-Navarro GM, Krylova Y, Leon-Acuna A, Luque RM, Gomez-Delgado F, Delgado-Lista J, Ordovas JM, Perez-Martinez P, Camargo A, Lopez-Miranda J A set of miRNAs predicts T2DM remission in patients with coronary heart disease: from the CORDIOPREV study Mol Ther Nucleic Acids (2021) 23:255-63
Palomo L, Santiago-Vacas E, Pascual-Figal D, Fuster JJ, Solé F, Bayés-Genís A Prevalence and characteristics of clonal hematopoiesis in heart failure Rev Esp Cardiol (2021) 74:996-999
Romero Daza A, Chokshi A, Pardo P, Maneiro N, Guijarro Contreras A, Larrañaga-Moreira JM, Ibañez B, Fuster V, Fernández Friera L, Solís J, Sanz J Mitral valve prolapse morphofunctional features by cardiovascular magnetic resonance: more than just a valvular disease J Cardiovasc Magn Reson (2021) 23:107
Fernández-Alvira JM, Fernández-Jiménez R, de Miguel M, Santos-Beneit G, Bodega P, Hill CA, Carral V, Rodríguez C, Carvajal I, Orrit X, de Cos-Gandoy A, Re MD, Robledo T, Fuster V The challenge of sustainability: long-term results from the Fifty-Fifty peer group-based intervention in cardiovascular risk factors Am Heart J (2021) 240:81-88
Asensio-Lopez MC, Sassi Y, Soler F, Fernandez Del Palacio MJ, Pascual-Figal D, Lax A The miRNA199a/SIRT1/P300/Yy1/sST2 signaling axis regulates adverse cardiac remodeling following MI Sci Rep (2021) 11:3915